OBJECTIVES The aim of this study was to investigate the vascular responses and fates of the scaffold after bioresorbable vascular scaffold (BVS) implantation using multimodality imaging.
A drug-eluting stent (DES) prevents repeat revascularization more efficiently than a bare-metal stent and is currently a standard treatment device in percutaneous coronary intervention (1) . However, the permanent presence of metallic foreign material could cause late complications such as metallic stent fractures, late restenosis, and neoatherosclerosis (2, 3) , resulting in a steady increase of stent-related events in the long term (4). (8, 9) . However, long-term clinical results from these pivotal trials demonstrated that there were higher risks for device thrombosis with the BVS than with the CoCr-EES during the time period when bioresorption was still ongoing (10). The safety concerns raised by these results and the low market share of the device forced the manufacturer to discontinue marketing the device. Nevertheless, to improve bioresorbable scaffolds further, it is essential to investigate the long- Lung Institute, Imperial College London, London, United Kingdom. The sponsor (Abbott Vascular) was involved in study design, data collection, data analysis, data interpretation, and writing of this report. The corresponding author had full access to the analyzed data in the study and accepts full responsibility for the integrity of the study and the decision to submit for publication. Strut discontinuities were assessed on OCT as the presence of overhang or stacked struts, categorized into 4 groups from high to low ranking: "uncovered and malapposed," "uncovered and apposed,"
"covered and malapposed," and "covered and apposed." If more than 1 condition was present in 1 lesion, the lesion was classified with the worst ranking. Figure S1 ). Minimum flow area was numerically smaller at post-procedure and significantly smaller at 2 and 3 years in the BVS arm than in the CoCr-EES arm ( Table 1 , Online Table S5 ). In the serial analysis, minimum flow area decreased significantly between 2 and 3 years in the BVS arm but not in the CoCr-EES arm (Figure 2 , Online Table S6 ).
Minimum scaffold or stent area was also numerically smaller at post-procedure and significantly smaller at 2 and 3 years in the BVS arm than in the CoCr-EES arm ( Table 1 , Online Table S5 ). In the serial analysis, Table S7 ).
At 3 years, the coverage of struts was complete in both arms, whereas lesions with incomplete strut apposition were less frequent in the BVS arm than in the CoCr-EES arm ( Table 1 , Online Table S5 ). Qualitative light intensity analysis of neointima demonstrated that homogeneous neointima was more frequently observed in the BVS arm than in the CoCr-EES arm at 3 years (Online Table S5 ). The healing score was optimal in both arms (Table 1, Figure 3 , Online Table S5 ).
At 3 years, strut discontinuities were found in 70 cases (54%) in the BVS arm, 52 of which were covered and apposed. There were 3 cases with strut discontinuities in the CoCr-EES arm, which were presumably due to deformation of proximal edge of stent caused by guiding catheter or other interventional devices (Online Figure S3 ). In 18 cases (14%), discontinued struts were either uncovered and/or malapposed (intraluminal scaffold dismantling). Of 5 cases with very late scaffold thrombosis of BVS, strut discontinuities were detected in all 4 cases by OCT performed just before reintervention ( Figure S2 , Online Table S8 ) (15) .
In the serial analysis in the OCT-1 group, there were 6 lesions (8%) with intraluminal scaffold dismantling at 2 years, in all of which struts were fully apposed at post-procedure (Online Figure S4) . At 3 years, there were 12 lesions (18%) with intraluminal scaffold dismantling, in 8 of which there were no discontinuities or only covered and apposed discontinuities at 2 years, suggesting that new intraluminal scaffold dismantling occurred between 2 and 3 years even from struts without any discontinuity (Central Illustration, Online Tables S5 and S9 ).
QCA AND IVUS FINDINGS. The details of QCA and IVUS findings are presented in Table 1 , Figures 2 and 3 , and the Online Tables S10 and S11. On quantitative coronary angiography, change in mean luminal diameter after intracoronary injection of nitrate was not significantly different between the 2 arms (BVS 0.06 AE 0.11 mm vs. CoCr-EES 0.06 AE 0.11 mm; p ¼ 0.69) (Online Table S10 ). In the serial IVUS analysis, mean vessel area was unchanged not only in the CoCr-EES arm but also in the BVS arm, suggesting no positive vessel remodeling in the BVS arm ( Figure 2 ).
There were also few cases with expansive vessel remodeling in the BVS arm (9.7%) (Online Figure S5 ).
DISCUSSION
The main findings in the ABSORB Japan 3-year multimodality serial imaging assessment were the following: 1) Luminal dimension at 3 years was smaller in the BVS arm than in the CoCr-EES arm Image Assessments in the ABSORB Japan Trial J A N U A R Y 1 3 , 2 0 2 0 : 1 1 6 -2 7
